The venom gland transcriptome of the parasitoid wasp  highlights the importance of novel genes in venom function by unknown
RESEARCH ARTICLE Open Access
The venom gland transcriptome of the
parasitoid wasp Nasonia vitripennis
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Abstract
Background: Prior to egg laying the parasitoid wasp Nasonia vitripennis envenomates its pupal host with a
complex mixture of venom peptides. This venom induces several dramatic changes in the host, including
developmental arrest, immunosuppression, and altered metabolism. The diverse and potent bioactivity of N.
vitripennis venom provides opportunities for the development of novel acting pharmaceuticals based on these
molecules. However, currently very little is known about the specific functions of individual venom peptides or
what mechanisms underlie the hosts response to envenomation. Many of the venom peptides also lack
bioinformatically derived annotations because no homologs can be identified in the sequences databases. The RNA
interference system of N. vitripennis provides a method for functional characterisation of venom protein encoding
genes, however working with the current list of 79 candidates represents a daunting task. For this reason we were
interested in determining the expression levels of venom encoding genes in the venom gland, as this information
could be used to rank candidates for further study. To do this we carried out deep transcriptome sequencing of the
venom gland and ovary tissue and used RNA-seq to rank the venom protein encoding genes by expression level.
The generation of a specific venom gland transcriptome dataset also provides further opportunities to investigate
novel features of this specialised organ.
Results: RNA-seq revealed that the highest expressed venom encoding gene in the venom gland was ‘Venom
protein Y’. The highest expressed annotated gene in this tissue was serine protease Nasvi2EG007167, which has
previously been implicated in the apoptotic activity of N. vitripennis venom. As expected the RNA-seq confirmed
that venom encoding genes are almost exclusively expressed in the venom gland relative to the neighbouring
ovary tissue. Novel genes appear to perform key roles in N. vitripennis venom function, with over half of the 15
highest expressed venom encoding loci lacking bioinformatic annotations. The high throughput sequencing data
also provided evidence for the existence of an additional 472 previously undescribed transcribed regions in the N.
vitripennis genome. Finally, metatranscriptomic analysis of the venom gland transcriptome finds little evidence for
the role of Wolbachia in the venom system.
Conclusions: The expression level information provided here for the N. vitripennis venom protein encoding genes
represents a valuable dataset that can be used by the research community to rank candidates for further functional
characterisation. These candidates represent bioactive peptides valuable in the development of new pharmaceuticals.
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Background
Nasonia vitripennis (Hymenoptera: Pteromalidae) (here
after Nasonia) is a parasitoid wasp that utilises species
of cyclorrhaphous diptera, such as house flies and blow
flies, as hosts to support the growth and development of
their offspring. Envenomation of the host increases the
overall nutritional value of the food source available to
the feeding wasp larvae. Some of these venom induced
changes include developmental arrest, immune suppres-
sion and changes to the overall metabolite profile of the
host [1–3]. The diverse and potent bioactivities of Naso-
nia venom peptides indicate that they may be useful in
the development of novel pharmaceuticals [1, 4–7]. The
venom peptides themselves are synthesised in the venom
gland (VG) before being secreted into the venom reser-
voir ready for injection into the host via the ovipositor
[8]. A recent proteomic study on these venom reservoir
extracts was able to identify 79 peptides [4, 9]. Although
several of the peptides had similarity to sequences found
in the venom of other animals, a majority had either not
been associated with venom before or had no homology
to sequences in the National Centre for Bioinformatic
Information (NCBI) databases. Bioinformatic based an-
notation categories that could be applied to the venom
peptides included immunity, metabolism, esterases, pro-
teases, and recognition proteins [9]. The most prevalent
functional annotation was serine proteases, which is one
of the largest gene families found in insect genomes [4, 10].
The response to Nasonia envenomation by the
common laboratory host Sarcophaga bullata (Diptera:
Sarcophagidae) has been extensively studied at both
the molecular and physiological level. Experiments
show that the respiration rate of S. bullata remains stable
for up to 2 weeks following envenomation (although at
lower levels than unstung hosts) indicating that the venom
is not immediately lethal to this host [11]. Other physio-
logical changes to the host associated with envenomation
include an increase in lipids and free amino acids, as well
as the initiation of developmental arrest through an as yet
an unknown mechanism. S. bullata immune processes are
also affected, with the abundance and potency of circulat-
ing plasmatocytes declining dramatically (due to cell
death) 60 min following envenomation by Nasonia [12].
Importantly, Nasonia venom has been shown to be able to
interfere with mammalian immunity pathways. For ex-
ample, experiments using mouse cell lines demonstrated
that Nasonia venom has both antimicrobial and anti-
inflammatory properties [6]. Reporter assays provided evi-
dence that the observed immune responses were mediated
through venom specific modifications to the steroid and
Toll pathways [6]. The activity of Nasonia venom in mam-
malian systems may indicate that venom peptides have
evolved to target highly conserved core pathway compo-
nents in order to limit the ability of the host to escape
envenomation. In this situation evolution has already done
much of the work in designing highly specialised peptides
that target cellular pathways involved in diseases such as
hypertension, diabetes, and cancer. Thus given the incred-
ible species richness of the parasitoid wasps their venoms
may represent a diverse untapped reservoir of molecules
ready for incorporation into drug development pipelines.
In contrast to the extensive body of work exploring
the host response to envenomation, relatively little is
known about the individual venom peptides responsible
for inducing these changes. Based on sequence homology
a Nasonia venom metalloproteinase has been proposed to
initiate developmental arrest by interfering with Notch
signalling [1, 7, 13]. Supporting this proposal is the obser-
vation that several notch pathway genes are differentially
expressed in the S. bullata hosts following envenomation.
However, currently there is no direct evidence showing
that this venom metalloprotease is specifically responsible
for the observed expression changes in the Notch pathway
[1]. Several other venom peptides are thought to be in-
volved in modifying host metabolic pathways based on
homology to sequences from model systems. For example,
a venom lipase could be responsible for the increase in
phospholipid degradation observed in envenomated hosts
[2, 14]. A venom trehalase has been proposed to convert
the abundant host trehalose sugars into glucose [2].
Additionally, several proteases found in Nasonia venom are
homologous to peptides used by the ectoparasitoid Euplec-
trus separatae and the tick Haemaphysalis longicornis for
blood meal digestion [15, 16].
The most direct functional characterisation of a venom
encoding gene comes from a recent RNA interference
(RNAi) study by Siebert et al. (2015). Knockdown of
Nasonia venom calreticulin (Nasvi2EG037342) resulted
in an increase in melanisation occurring at the ovipos-
ition wound on the host following envenomation [5].
This observation suggested that venom calreticulin func-
tions to interfere with normal wound healing in the host,
perhaps by competing with the endogenous calreticulin
in the host for binding of cofactors [17].
Several endoparasitoids from the Braconidae and
Ichneumonidae wasp families inject viruses or virus like
particles along with their venom in order to prevent the
host immune system from attacking eggs deposited in the
haemolymph. The virus like particles appear to provide
protection to the developing parasitoid by induction apop-
tosis in host hemocytes [18–22]. As yet viral-like particles
have not been implicated in Nasonia venom function and
viral transcripts could not be identified in cDNA libraries
synthesised from envenomated hosts [23]. The intracellu-
lar symbiont Wolbachia is also present in high concentra-
tions in the ovaries and host envenomation has been
proposed as a possible mechanism for horizontal transfer
of strains between parasitoid species [24].
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Currently there is little direct experimental evidence
supporting the proposed functions of the 79 Nasonia
venom proteins and many of the bioinformatic annotations
are based on homology to sequences from non-venomous
model organisms. The RNAi knockdown system of
Nasonia clearly provides an opportunity to begin to
functionally characterise the venom protein encoding
genes [5]. However, given the number of genes involved,
an important first step would be the identification of high
value candidates. For this reason we carried out deep se-
quencing of the NasoniaVG and ovary in order to use the
relative gene expression as a proxy for protein abundance
in the venom reservoir. The RNA-seq information gener-
ated in this study also provides a valuable dataset for fu-
ture studies into the reproductive system of this important
developing model system.
Results
RNA-seq analysis of the Nasonia VG and ovary
transcriptomes
We used RNA-seq to measure the expression of venom
protein encoding genes in the VG and ovary. We chose
the ovary as the comparative tissue because although it
is connected to the venom apparatus, it clearly performs a
distinct function in Nasonia reproduction. High through-
put sequencing of VG and ovary RNA-seq libraries
(three biological replicates each tissue) generated a total of
92.7 million and 97.9 million of high quality reads (phred
quality score >20), respectively. On average 90.7 % of the
sequenced reads successfully mapped to the published
Nasonia genome [4] (Table 1). The lower mapping per-
centages observed for VG sample three (“VG 3” in Table 1)
was due to a higher proportion of rRNA reads in this
sample. We predict that this resulted from less effective
rRNA removal during library preparation for this repli-
cate. Apart from the higher proportion of Nasonia
rRNA reads other quality control parameters for this
replicate were consistent with those obtained from the
other samples (Fig. 1a and Table 1).
Overlap between the mapped reads and annotated fea-
tures in the Nasonia official gene set version 2 (OGS2)
is high, with an average of 81 % of mapped reads align-
ing to at least one gene body (Table 1). Of the 36,329 an-
notated genes in OGS2, 54 % (19,854) had detectable
expression in either the VG or ovary. Based on normal-
ised read counts, tissue specific expression (reads for a
gene model detected in only one tissue) was observed
for 3475 genes in the ovary and 1424 genes in the VG.
Next we utilised the R-package DESeq to identify differen-
tially expressed genes between the VG and ovary RNA-seq
datasets [25]. Significantly different expression was ob-
served for 5794 (16 % of OGS2 loci) genes at an adjusted
p-value threshold of 0.05 (Benjamini-Hochberg adjusted
for multiple testing) (Figs. 1b and c; Additional file 1). Of
the differentially expressed genes, 2524 were up and 3270
were down regulated in the VG relative to the ovary.
Overall the fold changes of upregulated genes were signifi-
cantly larger in the VG versus the ovary (Student’s t-test
p-value < 0.001) (Fig. 1b).
Using Blast2GO we then looked for GO term enrich-
ment amongst the genes either significantly upregulated
in the ovary or VG tissues. The reproductive function of
the ovary is characterised by several GO terms related to
cell division and transcription (Fig. 2a). In contrast,
genes significantly upregulated in the VG showed GO
enrichment in terms related to translation and protein
processing functions (Fig. 2b). The relatively narrow GO
functional categorisations of genes upregulated in the
VG are likely to reflect that the major model systems are
non-venomous.
The highly expressed venom protein encoding genes
Previous proteomic studies on Nasonia venom reservoir
extracts identified 79 venom peptides. Based on our VG
RNA-seq data we were able to detect expression from all
but one of these venom protein encoding genes (Table 2).
Nasonia venom genes were significantly more likely to
be expressed at higher levels in the VG relative to the
ovary (70 of 79 genes; Chi-square p-value < 0.0001 with
Yates correction). The DESeq analysis showed that six of
the venom protein encoding genes were expressed at
equal levels in the VG and ovary (Table 2). Two venom
Table 1 RNA-seq statistics of Nasonia vitripennis ovary and VG tissue
Sample Total Reads Mapped (%) Assigned (%)a Multiple Alignments (%)b No Feature (%)c
VG 1 2.89E + 07 95.62 88.08 3.63 1.99
VG 2 3.24E + 07 96.15 87.31 3.37 1.97
VG 3 3.14E + 07 67.03 59.65 3.54 4.32
Ovary 1 3.31E + 07 95.17 85.51 1.43 5.95
Ovary 2 3.42E + 07 95.16 84.06 1.46 6.34
Ovary 3 3.06E + 07 95.16 84.18 1.43 6.13
aProportion of reads which could be aligned to a gene model
bProportion of reads assigned to multiple gene models
cProportion of aligned reads that did not overlap a gene model
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protein encoding genes expressed at higher levels in the
ovary than the VG were a aspartylglucosaminidase
(Nasvi2EG015708) and trehalase (Nasvi2EG008324).
The highest expressed venom encoding gene based on
normalised venom gland read counts was the novel gene
Venom protein Y (Nasvi2EG013868). A trypsin-like serine
protease (Nasvi2EG007167) was the highest expressed an-
notated gene in the VG (Table 3). The RNA-seq data and
semi-quantitative PCR showed that expression of Nas-
vi2EG007167 was highly tissue specific (Fig. 1d). Only five
of the top 15 highest expressed venom protein encoding
genes had functional annotations, highlighting the unique
functional properties of Nasonia venom (Tables 2 and 3).
Next we used sequence homology based clustering to
identify any relationships amongst the highly expressed
unannotated genes. Using this approach only two small
clusters of unannotated venom encoding genes were iden-
tified (V/Z and L/K), suggesting that most of these novel
loci have evolved independently, rather than through an
expansion of a single gene cluster (Additional file 2).
Calreticulin (Nasvi2EG037342) was the highest ovary
expressed venom encoding gene, which is not surprising
given it also functions as a core immune response gene
[26–28]. The single venom encoding gene that was not
expressed in our venom dataset, a trypsin-1 serine protease
(Nasvi2EG011442), also had very little expression in the
ovary (Fig. 3 and Table 2).
RNA-seq identifies 472 novel genes
The generation of the official gene set for Nasonia did
not include evidential sequencing data specifically ob-
tained from VG samples, so we predicted that genes
expressed in this relatively small organ might be under-
represented in the current gene models. Therefore, we
used the Cufflinks software package to identify novel
genes based on mapped reads that did not overlap with
any current annotations in OGS2 [29] (Additional file 3).
This approach identified 472 putative genes from both VG
and ovary datasets (Additional file 4). We merged these
new gene models into the official gene set and repeated the
DESeq differential expression analysis (Additional file 5).
This showed that 140 (30 %) of the novel genes were sig-
nificantly upregulated and 56 (12 %) were significantly
down regulated in the VG tissue; the remaining 276 genes
(58 %) were not differentially expressed between the
tissues (Fig. 4). The highest expressed novel genes in
both the VG and ovary were shown to be highly tissue
specific. The most differentially expressed novel VG gene
(based on fold change) XLOC_013208 was also predicted
to have an alternate splice form that truncated exon 3
Fig. 1 RNA-seq highlights expression differences between ovary and VG tissue. a Principal component analysis of expression profiles for ovary
(green) and VG (blue) replicates showing the samples clustering by treatment group. The percentage on the axis labels represents the total
variance explained by that component (b) Volcano plot of the RNA-seq data with positive fold change representing up regulated genes in the
VG and vice versa for ovary. Genes coloured as red were differentially expressed at an adjusted p-value < 0.05. c Pie chart summarising the proportion
of genes that were part of each expression category (adjusted p-value < 0.05). d Semi-quantitative RT-PCR targeting the highest expressed
annotated venom encoding gene Nasvi2EG007167. Amplification of Nasvi2EG007167 cDNA could be detected at 24 cycles in the venom
gland cDNA replicates, whilst only a faint band could be detected at 30 cycles for the ovary samples. The house-keeping gene RP49 was
used as a loading control. VG1-3 and O1-3 represent independent replicates for venom gland and ovary samples, respectively
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(Fig. 5). Unfortunately, the putative proteins encoded by
XLOC_013208 splice forms have no homology to any
domains in the database so we are not able to predict pos-
sible functional consequences of this splicing event. As a
result of low homology to sequences in the NCBI database
only ten of the 472 novel genes identified here could be
annotated with gene ontology terms using Blast2GO
(Table 4). Extending the Cufflinks splice form prediction
methodology to the currently annotated venom protein
encoding genes failed to identify any significant alternative
splice forms between the VG and ovary transcriptomes.
Expression of venom protein encoding genes previously
identified as high value candidates
Using our data we were then able to examine the ex-
pression pattern of genes previously identified as high
value venom candidates based on bioinformatic annota-
tions or results from studies in other venomous species
[7, 9]. To differentiate the genes based broadly on their
expression level we placed the 79 venom protein encoding
genes into high, medium or low expression categories
based on three equal divisions of normalised counts across
our entire dataset (see methods). These categories were
defined by normalised read count ranges of <181700,
181701-1218700,>1218701 for low, medium and high,
respectively.
The highly expressed category was dominated by novel
venom genes (Venom proteins G, Q, X, Y, and Z), with
the single annotated loci being the trypsin-like serine
protease Nasvi2EG007167 (Table 2). Serine proteases
play broad functional roles across insect physiology,
including apoptosis, immunity, and development [30, 31].
The medium expression category includes the gamma-
glutamyltranspeptidase and endonuclease-like venom
genes, which have been previously implicated in initiating
venom induced apoptosis by interfering with normal me-
tabolism of glutathione and by degrading nuclear DNA,
respectively [7, 32, 33]. Similarly, the aminotransferase-
Fig. 2 GO terms related to ribosomal function, translation, and protein processing are enriched in the VG. Enriched GO terms amongst the
subset of genes significantly upregulated in the ovary (a) and VG (b). The bar graph represents the proportion (in percentage) of sequences in
the differentially expressed subset (blue) with the indicated functional annotation, compared to the proportion of these annotations assigned to
the entire gene set (red)
Sim and Wheeler BMC Genomics  (2016) 17:571 Page 5 of 16
Table 2 Summary of VG and ovary RNA-seq data for the 79 Nasonia venom protein encoding genes
Gene ID Ovary read countsb VG read countsb Log2 Fold Change
c Adj p-val Classification
Higha Nasvi2EG013868 141 4600307 15.00 2.33E-127 Venom protein Y
Nasvi2EG009648 76 2859048 15.20 7.49E-129 Venom protein G
Nasvi2EG009662 93 2701601 14.82 7.75E-126 Venom protein Z
Nasvi2EG009647 90 2310849 14.65 2.5E-124 Venom protein Q
Nasvi2EG014072 75 2063715 14.75 4.41E-85 Venom protein X
Nasvi2EG007167 43 1532232 15.11 7.49E-129 Serine protease
Mediuma Nasvi2EG003930 49 1218607 14.61 5.88E-123 Serine protease inhibitor 2
Nasvi2EG014069 26 976928 15.20 1.2E-106 Venom protein L
Nasvi2EG006243 25 819734 15.03 5.88E-111 γ-glutamyltranspeptidase
Nasvi2EG012348 23 756942 15.04 1.14E-125 Venom protein H
Nasvi2EG009035 22 666528 14.92 5.13E-127 Endonuclease-like
Nasvi2EG036525 18 660159 15.17 4.8E-129 Aminotransferase-like
Nasvi2EG008596 25 595426 14.56 7.8E-121 Venom protein P
Nasvi2EG009661 21 590933 14.80 1.37E-124 Venom protein V
Nasvi2EG002524 11 386873 15.11 1.45E-74 Venom protein I
Nasvi2EG001168 68 385586 12.47 3.96E-92 Immunoglobulin-like
Nasvi2EG014575 10 312136 14.94 1.22E-99 Venom protein K
Nasvi2EG010245 10 257730 14.72 4.26E-84 Odorant-binding protein
Nasvi2EG019091 48 245164 12.31 4.4E-13 Venom protein M
Nasvi2EG010351 7 197286 14.79 1.09E-124 Glucose dehydrogenase-like
Nasvi2EG004342 6 181642 14.97 9.19E-125 Lipase-like
Nasvi2EG016543 12 155729 13.63 3.31E-110 Venom protein N
Nasvi2EG007615 4 153498 15.08 1.03E-125 Lipase
Nasvi2EG021024 737 149042 7.66 3.33E-50 Serine protease homologue
Nasvi2EG009991 4 145328 15.06 3.41E-127 Acid phosphatase
Nasvi2EG020297 387 141654 8.52 6.11E-59 Serine protease/CLIP
Nasvi2EG022918 4 130887 14.97 7.1E-125 Serine protease
Nasvi2EG008779 4 115742 14.82 1.21E-124 Aminotransferase-like
Nasvi2EG000667 5 104214 14.48 1.04E-119 Serine proteinase inhibitor
Nasvi2EG004628 8 98159 13.59 4.58E-65 Venom protein D
Nasvi2EG000354 7 91416 13.72 2.06E-19 Cysteine-rich/TIL 1
Nasvi2EG016421 91 90433 9.96 9.19E-65 α-Esterase
Nasvi2EG004144 5 81771 14.02 6.13E-19 Venom protein T
Nasvi2EG037101 6 77272 13.57 2.54E-48 Chitin binding protein-like
Nasvi2EG019611 2 75339 15.19 5.42E-125 Laccase
Nasvi2EG020586 2 66726 15.06 9.42E-120 Serine protease
Nasvi2EG013736 54 64975 10.24 2.62E-45 Serine protease inhibitor 1
Nasvi2EG020997 1 63251 15.64 7.83E-121 Venom protein J
Nasvi2EG026553 4 46698 13.56 3.89E-109 Lipoprotein receptor-like
Nasvi2EG020296 716 42847 5.90 1.43E-32 Serine protease/CLIP
Nasvi2EG006920 3 42299 13.91 9.42E-113 Arylsulphatase b
Nasvi2EG002112 224 38349 7.42 1.67E-47 β-1,3-Glucan recognition
Nasvi2EG022916 2 38281 14.41 4.45E-79 Serine protease
Nasvi2EG000112 18 34599 10.87 3.97E-83 Apyrase
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like venom gene encodes an enzyme predicted to produce
kynurenic acid from kynurenine and this may also be
involved in apoptosis [34, 35]. Other medium expression
category genes of note include IMPL-L2, enzymes involved
in carbohydrate metabolism, and several serine proteases/
proteinase inhibitor genes. Insulin binding protein
(Nasvi2EG001168) is possibly involved in initiating the de-
velopmental arrest by blocking insulin signalling [7, 36].
The majority of venom protein encoding genes fit into
the low expressed category based on our designations.
Notable venom protein encoding genes in the low ex-
pression group include apyrase, beta-1-3-Glucan recog-
nition protein, dipeptidyl peptidase, metalloprotease,
trehalase, chitinase, and all five of the venom cystein-
rich/Pacifastin protease inhibitors (Table 2). The first
three of these aforementioned genes have been proposed
Table 2 Summary of VG and ovary RNA-seq data for the 79 Nasonia venom protein encoding genes (Continued)
Nasvi2EG022914 1 33717 14.50 1.78E-111 Serine protease
Nasvi2EG037342 3926 33363 3.09 3.21E-04 Calreticulin
Nasvi2EG004152 18 26602 10.57 2.07E-79 Venom protein R
Nasvi2EG020295 1 24624 14.74 1.28E-113 Serine protease/CLIP
Nasvi2EG005749 1 23005 14.93 1.58E-59 Serine protease
Nasvi2EG013838 711 22562 4.99 5.35E-11 Venom protein F
Nasvi2EG011463 1 20535 14.43 9.18E-110 Inositol phosphatase
Nasvi2EG004824 3 19029 12.49 6.8E-51 Venom protein E
Lowa Nasvi2EG006071 1 18923 14.14 9.03E-97 Venom protein S
Nasvi2EG023753 103 12408 6.91 3.68E-42 Dipeptidylpeptidase IV
Nasvi2EG013885 1 9901 13.00 2.6E-102 γ-Glutamyl transpeptidase 2
Nasvi2EG005790 1 8481 13.24 6.37E-25 Antigen-5 like
Nasvi2EG006543 30 7665 8.00 2.54E-40 γ-Glutamyl cyclotransferase-
Nasvi2EG016379 0 7408 15.24 3.96E-78 Venom protein U
Nasvi2EG005645 0 5919 13.75 5.86E-31 Venom protein O
Nasvi2EG007282 390 4909 3.65 1.54E-09 Serine protease
Nasvi2EG000351 84 3807 5.51 1.44E-01 Cysteine-rich/TIL 2
Nasvi2EG008007 5 1805 8.46 3.43E-27 Angiotensin-converting
Nasvi2EG022626 326 532 0.71 6.18E-01 Serine protease/CUB
Nasvi2EG009433 47 426 3.17 1.90E-04 Cysteine-rich/KU
Nasvi2EG000909 93 147 0.66 4.82E-01 C1q-like venom protein
Nasvi2EG009664 1 110 6.65 1.19E-03 Cysteine-rich/Pacifastin 1
Nasvi2EG009665 4 93 4.62 2.44E-03 Cysteine-rich/Pacifastin 2
Nasvi2EG012510 5 83 4.17 1.23E-04 Chitinase 5
Nasvi2EG012285 9 77 3.15 1.94E-05 Acid phosphatase
Nasvi2EG015708 929 68 −3.76 1.14E-15 Aspartylglucosaminidase
Nasvi2EG008324 200 62 −1.70 4.03E-04 Trehalase
Nasvi2EG007347 18 41 1.19 1.00E + 00 Serine protease
Nasvi2EG005784 1 21 4.63 3.49E-02 Antigen 5-like protein
Nasvi2EG010516 3 20 2.88 1.03E-02 Metalloprotease
Nasvi2EG007166 0 16 N/A 4.85E-06 Serine protease
Nasvi2EG015589 1 8 3.37 7.42E-03 Laccase
Nasvi2EG021414 0 3 4.23 3.08E-01 Nucleoside hydrolase
Nasvi2EG011314 0 1 N/A 7.67E-01 Venom protein W
Nasvi2EG011442 1 0 N/A 1.00E + 00 Serine protease
aExpression category, see methods for details
bLibrary size normalised read counts from DESeq divided by transcript length (in kb) and sorted in descending order based on the venom gland values
cFold changes calculated directly from library size normalised read counts by DESeq
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to be involved in modifying the host immune response
[7, 37, 38]. The metalloprotease has been suggested to
be involved in venom induced developmental arrest by
interfering with normal Notch signalling [1]. The treha-
lase gene important for metabolising carbohydrates is
also one of the few such genes expressed at higher levels
in the ovary in our dataset. As noted by [7] the observa-
tion of proteins normally associated with breakdown of
the chitin rich cuticle is somewhat puzzling given Naso-
nia larvae are able to mechanically access the host
hemolymph using their mandibles [7, 39]. Antigen 5-like
protein and the cystein-rich/pacifastin protease inhibi-
tors have been identified in the venom of the Apis melli-
fera and Pimpla hypochondriaca [40, 41].
Metatranscriptomic analysis of Nasonia VG and ovary tissue
Finally, although the library preparation method in-
cluded an mRNA enrichment step, we were interested in
looking for any evidence for the involvement of bacteria
(such as Wolbachia) or viruses in Nasonia venom func-
tion. Therefore, we performed a metatranscriptomic ana-
lyses of reads that did not align to the Nasonia genome
Table 3 Highest 15 expressed genes in the VG and ovary sorted in descending order by normalised read counts
Venom gland data
Gene ID Ovary normalised countsb VG normalised countsb Log2 Fold Change
c Adj p-val Classification
Nasvi2EG013868a 141 4600307 15.00 2.33E-127 Venom protein Y
Nasvi2EG009648a 76 2859048 15.20 7.49E-129 Venom protein G
Nasvi2EG009662a 93 2701601 14.82 7.75E-126 Venom protein Z
Nasvi2EG009647a 90 2310849 14.65 2.50E-124 Venom protein Q
Nasvi2EG014072a 75 2063715 14.75 4.41E-85 Venom protein X
Nasvi2EG021198 62 1557446 14.61 6.16E-55 Unknown
Nasvi2EG007167a 43 1532232 15.11 7.49E-129 Serine Protease
Nasvi2EG003930a 49 1218607 14.61 5.88E-123 Serine protease inhibitor 2
Nasvi2EG009363 54 1217247 14.45 5.14E-121 Unknown
Nasvi2EG014069a 26 976927 15.20 1.20E-106 Venom protein L
Nasvi2EG006243a 25 819734 15.03 5.88E-111 γ-glutamyltranspeptidase
Nasvi2EG012348a 23 756942 15.04 1.14E-125 Venom protein H
Nasvi2EG011080 20 722740 15.15 3.50E-126 Unknown
Nasvi2EG009035a 22 666528 14.92 5.13E-127 Endonuclease-like
Nasvi2EG036525a 18 660159 15.17 4.80E-129 Aminotransferase-like 2
Ovary data
Nasvi2EG004175 35984 37 −9.92 4.96E-65 Unknown
Nasvi2EG002830 34980 10187 −1.78 7.40E-05 HEAT shock 70
Nasvi2EG000341 29283 27085 −0.11 1 CCHC-type zinc finger
Nasvi2EG007353 29093 708.41 −5.36 2.33E-32 ATP-dependent RNA helicase
Nasvi2EG002390 25623 73530 1.52 2.81E-3 40S ribosomal protein
Nasvi2EG006904 25600 45210 0.82 2.70 E-1 Elongation factor 1-alpha
Nasvi2EG011214 25321 70701 1.48 2.69E-2 40S ribosomal protein
Nasvi2EG020214 25158 139912 2.48 1.38E-4 60S acidic ribosomal protein
Nasvi2EG004598 25153 72614 1.53 2.70E-3 60S ribosomal protein
Nasvi2EG007380 23250 117959 2.34 1.28E-3 60S acidic ribosomal protein
Nasvi2EG019818 23062 85908 1.90 1.68E-4 40S ribosomal protein
Nasvi2EG003839 22711 103851 2.20 1.39E-05 60S ribosomal protein
Nasvi2EG007413 22602 92995 4.11 5.36E-05 40S ribosomal protein
Nasvi2EG011575 21836 57655 2.64 2.21E-2 60S ribosomal protein
Nasvi2EG014261 21805 219749 10.08 3.29E-11 Unknown
aIndicates venom protein encoding gene
bLibrary size normalised read counts from DESeq, divided by transcript length (in kb) and sorted in descending order based on the venom gland values
cFold changes calculated from library size normalised read counts by DESeq
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[42, 43]. At the phylum level reads from both tissues could
be assigned to viruses (42.5 %), Nematoda (17 %), Chord-
ata (18 %) and Proteobacteria (5.5 %). A large proportion
of the unmapped reads were assigned to viruses, with
most of these being identified as an uncharacterised
‘Nasonia vitripennis virus’ (Taxonomic id #626355) (Fig. 6).
The nematode reads were assigned to Brugia malayi and
Trichuris trichiura, thus we initially suspected that this re-
sult may represent hits to the Wolbachia symbionts that
are associated with both of these species [44]. However,
subsequent megablast searches against the NCBI nr/nt
database with these reads revealed both the Nematoda
and Chordata groupings were based on low diversity
rRNA sequences that were taxonomically uninformative.
As expected a large proportion (87 %) of the Proteo-
bacteria reads from the ovary were assigned to Wolbachia
species (Fig. 7). In contrast relatively few reads could
be assigned to Wolbachia species in the Proteobacteria
grouping from the VG. Clostridium cellulosi and Strepto-
coccus anginosus were the most common species assign-
ments in the VG, however, relative to the abundance of
Wolbachia assigned reads in the ovary, very few reads
could be assigned at this narrow taxonomic level in the
VG data (Fig. 7). Thus based on this data there is little evi-
dence supporting a role for microorganisms in Nasonia
venom function.
Discussion
The expression levels of venom protein encoding genes
obtained in this study provides additional information
that can be used to select candidates for further func-
tional analysis using either RNAi or recombinant tech-
niques. The ovary RNA-seq also provides a proxy for the
tissue specificity of the venom encoding gene expression
that can be used to further refine candidate selection. It
should be noted that high venom gene expression does
Fig. 3 Venom genes were highly expressed in the VG. Log2 normalised gene counts for the 40 highest expressed (a), and 39 lowest expressed
(b), venom protein encoding genes (sorted by highest observed loci count). VG counts are shown in blue and ovary counts in orange
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not automatically imply that the encoded peptide is
responsible for important envenomation phenotypes.
Other biological features, such as translational regulators,
post-translational modifications and mRNA/protein
stability could also be critical to the function of gene
products in the venom context. Indeed, it has been
argued that as a result of extensive posttranslational
modifications, final venom protein composition is
largely independent of transcriptional control [45, 46].
The legitimacy of this view has been challenged by a
more recent study showing strong correlations between
the venom transcriptomes and proteomes of several
snake species [47]. Ultimately, additional high quality
quantitative proteomic and transcriptomic data will be
required to more fully appreciate the general importance
of posttranslational mechanisms on venom composition.
Finally, it is also worth considering that highly expressed
venom genes may perform accessory functions, such as
protecting the venom reservoir of the wasp from being
attacked by its own venom, as has been observed in
snakes [48].
The highest expressed annotated venom encoding
gene was a trypsin-like serine protease. Unfortunately,
serine proteases are a very common functional category
in insect genomes making it difficult to propose a role
for this highly expressed gene (especially in the venom
Fig. 4 Heatmap of normalised counts for the 100 highest expressed novel genes identified by cufflinks in the ovary and VG expression data. The
top 100 novel genes identified by cufflinks based on mean expression in the VG and Ovary colour coded by expression level. VG1-3 and O1-3
represent data from the three VG and ovary replicates, respectively. The dendrogram shows the clustering of samples based on euclidian distance
Fig. 5 Differential splicing of VG specific novel gene XLOC_013208. The coverage of mapped reads over the two predicted gene models for
XLOC_013208 the highest expressed novel gene in the VG. The coverage range is displayed in the square brackets in the top left corner of the
figure. The blue bar represents the gene model as predicted by cufflinks. The thick sections represent exons and the thin lines represent introns.
The rightward pointing arrows represent the orientation of the gene and the numbers above are for reference to the base pair position on
scaffold 29
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context). Previous studies using Sf21 cells have shown
that the apoptotic activity of Nasonia venom could be
reduced by the addition of serine protease inhibitors [49].
Interestingly, amongst the ten most highly expressed
venom protein encoding genes with annotations, all three
point to roles in apoptosis [7, 32, 33]. This may highlight
the importance of apoptosis for the early envenomation
effects, perhaps by assisting with the distribution of
venom throughout the host or by suppressing the immune
system by destroying circulating hemocytes [49]. Nasonia
venom has also been shown to induce apoptosis in S.
bullata neural tissue and this has been suggested as a
possible explanation for developmental arrest in enve-
nomated this host [50].
Perhaps the most dramatic finding from this study was
that over half of the top 15 expressed venom protein en-
coding genes have no functional annotation, including
the highest expressed gene ‘Venom protein Y’. In retro-
spect maybe this should not be surprising given the
complex evolutionary processes that drive specialisation
of venom peptides [51]. However, this observation does
highlight the value of candidate selection methods (such
as RNA-seq) that are not biased towards genes with
existing annotation information. Even for those genes
Table 4 Gene annotations of novel detected transcripts from Nasonia vitripennis VG and Ovary samples
Gene ID Classification GO terms
XLOC_005019 Atp-dependent dna helicase q4 metal ion binding, helicase activity, heterocyclic compound binding, organic cyclic
compound binding
XLOC_010355 Signal peptidase complex catalytic
subunit sec11a
signal peptide processing, integral to membrane, proteolysis, serine-type peptidase activity
XLOC_012101 N-acetylneuraminate lyase-like lyase activity, metabolic process
XLOC_013961 NADH dehydrogenase subunit 2 mitochondrial electron transport, NADH to ubiquinone, mitochondrial inner membrane, respiratory
chain, respiratory chain, NADH dehydrogenase (ubiquinone) activity, integral to membrane
XLOC_015645 NADH dehydrogenase subunit partial integral to membrane, mitochondrion, oxidation-reduction process, NADH dehydrogenase
(ubiquinone) activity
XLOC_016115 Uncharacterized aarf domain-
containing protein kinase 1
protein phosphorylation,oxidation-reduction process, protein kinase activity, ubiquinone
biosynthetic process, ATP binding, flavin adenine dinucleotide binding oxidoreductase activity,
acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one
donor, and incorporation of one atom of oxygen
XLOC_016465 60s ribosomal protein ribosome, structural constituent of ribosome, translation
XLOC_019886 28 s ribosomal protein mitochondrial ribosome, structural constituent of ribosome, translation
XLOC_020689 signal peptidase complex subunit 3 peptidase activity, signal peptide processing, integral to membrane, signal peptidase complex
XLOC_022279 inosine-5 -monophosphate
dehydrogenase 1b
oxidation-reduction process, adenyl nucleotide binding, metal ion binding, GMP biosynthetic
process, cytoplasm, IMP dehydrogenase activity
Fig. 6 Differences in metatranscriptomic composition of the VG and ovary. Distribution of reads that did not map to the Nasonia genome assigned to
the phylum level from the VG a and ovary b RNA-seq data by the program Megan
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that are bioinformatically annotated, it should be recog-
nised that most of the functional data comes from ex-
periments in model systems that are non-venomous.
Another interesting finding from this study is that
several venom peptides that have been previously impli-
cated in venom function were shown to be only lowly
expressed in our data [1, 7, 9]. Perhaps the best example is
the metalloprotease (Nasvi2EG010516) predicted to be in-
volved in initiating developmental arrest, was one of the
lowest expressed of the venom protein encoding genes in
our dataset [1, 52]. We also observed that all five cysteine
rich protease inhibitors suggested to be involved in
disrupting host immunity by inactivating the pro-phenol
oxidase cascade were also expressed at low levels [7]. The
low expression of chitinase-type venom genes also sug-
gests they may not be directly involved in venom function,
especially given Nasonia larvae are able to mechanically
disrupt the host integument during feeding.
Cufflink based transcript assembly of the VG and ovary
RNA-seq data allowed us to identify 472 previously unde-
scribed transcribed regions in the Nasonia genome. The
low expression and lack of homology to other known
genes might explain why they have not been previously
described. Alternatively these observations may indicate
Fig. 7 Proteobacteria species identified in the venom gland and ovary. Distribution of reads that did not map to the Nasonia genome, which can
be assigned to Proteobacteria species in the ovary and VG data by Megan
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they represent artefacts of the cufflinks methodology. Re-
evaluation of the raw venom proteomic data may enable
the identification of additional peptide fragments based on
these new gene models. It is worth noting that the OGS2
models were developed based on RNA-seq data from the
Wolbachia free Asymcx strain of Nasonia. As some of the
new gene models identified here could be induced by
Wolbachia infection they represent candidates for being
involved in the cytoplasmic incompatibility phenotypes in-
duced by this protobacteria.
Finally, the metatranscriptomic study revealed that vi-
ruses represented a large proportion of non-Nasonia
reads in the VG and ovary transcripts. Particularly
‘Nasonia vitripennis virus’, which has a positive strand
ssRNA genome and is part of the Picornavirales order
and the Iflaviridae family but remains unassigned to
lower taxonomic ranks [23]. ‘Nasonia vitripennis virus’
has a ssRNA genome so reads may be derived from ei-
ther messenger RNA or the ssRNA genome. The latter,
opens up the possibility of performing a de novo assem-
bly of the viral genome from our transcriptome data.
Studies have shown that this virus causes no observed
detrimental effect on Nasonia and it remains an open
question as to whether these transcripts end up in the
venom itself [23]. As expected the ovary metatranscrip-
tome was dominated by Wolbachia transcripts. In con-
trast, we identified relatively few Wolbachia sequences in
the VG, suggesting this bacteria is unlikely to play an im-
portant role in venom function. However, it is important
to note that the RNA-seq library preparation methods
used in our study enriched for poly A+ reads and thus
many bacterial sequences would not have been sequenced
in this experiment. Follow up experiments using total
RNA library preparation methods are required to conclu-
sively rule out a possible role for Wolbachia in Nasonia
venom function.
Animal venoms represent an important source of nat-
ural products with pharmaceutical value; as demonstrated
by the development of important drugs, such as Exenatide
from the Gila monster lizard, and Captopril isolated from
the venom of the lancehead viper [53]. More recently mol-
ecules isolated from reptile and arthropod venom have
been shown to have therapeutic value in the treatment of
cancer [54, 55]. With this in mind the venom of parasitoid
hymenoptera holds particular promise, given the incred-
ible species richness of this group of animals, a potentially
vast and unique source of molecules awaits discovery. We
also predict that venoms target highly conserved core
cellular pathways, as a mechanism to limit the ability of
the host to evolve detoxification strategies. Indeed, Naso-
nia venom has been shown to have bioactivity against
mammalian immune pathways, further highlighting the
pharmaceutical value of these molecules [6]. The results
reported here point to an important role for novel genes
in venom function, and this information should assist with
the selection of candidates in future functional studies.
Conclusions
In this study we used RNA-seq to generate a comprehen-
sive dataset of expression information for VG and ovary in
the developing model system Nasonia. Information on the
expression level of the 79 venom protein encoding genes
provides an unbiased approach for selecting RNAi candi-
dates, especially as bioinformatic annotations are likely to
be unreliable. As our knowledge of venom gene function
increases our ability to understand the fundamental mo-
lecular mechanisms underlying envenomation will also be
improved. This latter knowledge will be important in fu-
ture efforts to use Nasonia venom in drug development
pipelines.
Methods
Nasonia and tissue collection
The Nasonia (LABII strain) was a gift from Prof. Jack
Werren, University of Rochester, USA. The Nasonia
were hosted on Lucilia sericata pupae obtained from a
commercial insectary (Biosupplies Ltd). Venom gland
(VG) and ovary tissue from mated, host exposed, 1–3
day old females, was dissected under aseptic conditions
and placed immediately into ice cold Trizol (Ambion).
Each replicate contained VG or ovaries tissue pooled
from between 40 and 50 individuals.
RNA-seq and functional annotation
RNA was extracted using the modified RNeasy (Qiagen)
protocol. Briefly, tissue was initially homogenised in
1 ml of Trizol before the addition of 0.2 ml chloroform
(Merck). The sample was centrifuged at 10,000 rpm for
10 min at room temperature and the supernatant was
transferred to a Qiagen RNeasy column. The column
was centrifuged at 10,000 rpm for 15 s before the bound
RNA was washed twice with 0.5 ml Qiagen RPE buffer.
The RNA was eluted in 30 ul of RNase free water as de-
scribed in the RNeasy protocol. The quality of the purified
RNA was verified using a Bioanalyzer (Agilent) with all
samples having a RNA integrity score >7. Poly-T beads
were used to enrich for mRNA and TruSeq (Illumina)
stranded cDNA sequencing libraries were constructed by
the Otago Genome Service (NZGL). The 100 bp paired
end sequencing run was performed on the Illumina
HiSeq2500 platform.
The raw RNA-seq data was processed with fastq-mcf
to remove sequencing adapters and primers [56]. The
reads were quality trimmed to a Phred score of >20
using SolexaQA v3.1.3 [57]. The paired-end reads were
then mapped to the N. vitripennis genome [4] using
Tophat2 (version 2.1) with the default settings, except for
library type set as “fr-firststrand” based on the sequencing
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chemistry used during the library preparation [58]. Read
counts for gene feature in the N. vitripennis official gene
set version 2 were generated using HTSeq-count (version
0.6.1p) with ‘union mode’ on exon features and incorpor-
ating strand information [59].
Differential expression between the ovary and VG read
counts was determined using DESeq as described in the
package vignette [25, 60]. A gene was considered differ-
entially expressed if it had an adjusted p-value < 0.05.
Principal component analysis was performed using R
with the prcomp function. The heatmaps were generated
using heatmap.2 (ggplots CRAN package) and clustered
based on euclidean distance. A one-tailed enrichment
analysis for enrichment of functional categories was car-
ried out with Blast2GO using both the newly annotated
venom and ovary expressed genes as the target and the
entire gene set as the reference [61]. Soley for the
purposes of ranking genes based on expression level,
we divided the DESeq normalised read counts by the
transcript length (in kilobases) to compensate for the
effects of gene length on counts. These length normal-
ised counts are shown in Table 2 and Table 3 and also
provided in Additional files 1, 2, 3 and 4. The expres-
sion level boundaries of high, medium, and lowly
expressed venom genes were determined by binning all
genes into windows of expression of 100. A bin was
classified as low expressed if the value of the bin was
multiplied by its number of containing genes and this
value was less than a third of the sum of these values,
high if equal or greater than two thirds, and medium
elsewise.
The Cufflinks pipeline was used to identify putative
alternative transcripts as well as unannotated genes
based on comparisons to the current Nasonia gene
models as described in the package documentation
[29]. Novel transcripts were annotated using Blast2GO
v2.8 with the default parameters [61]. Normalised read
counts were generated for the new gene models by
merging the cufflinks models with those of OGS
version 2 and repeating the DESeq based analysis de-
scribed above.
Metatranscriptomics
Reads that did not align with the Nasonia genome using
Tophat2 were used in a Diamond BlastX search against
the NCBI non-redundant (nr) database. Results presented
do not include data from unmapped reads that were
discarded by Tophat2 during the generation of non-
redundant splice junctions. The high number of un-
mapped reads in the third VG sample necessitated that
only a random sample of 10 % of the reads from this
particular sample were used due to memory limitations.
Megan5 was used for visualisation of the taxonomic
distribution of reads in the data [42].
Semi-quantitative PCR
Complementary DNA was generated from 1 ug of RNA
extracted from dissected ovary and VG tissue using the
transcriptor first strand cDNA synthesis kit (Roche) as
described by the manufacturer. The PCR was then per-
formed using primers for the housekeeping gene RP49:
5’-CTTCCGCAAAGTCCTTGTTC-3’, 5’-TTTATTCAT
TCTCCTCAGAACG-3’. The primers specific for Nas-
vi2EG007167 were: 5’-TGGCTGTCATCAGATTGACG-3’,
5’-TATCCTGGAGCCAGTGTAG-3’. Reaction tubes were
removed at 24 and 30 cycles, at a denaturing temperature
of 94 °C for 30 s, annealing temperature of 55 °C for 30 s,
and extension temperature of 72 °C for 45 s with one unit
of taq polymerase (Roche).
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Additional file 2: Sequence based clustering of venom encoding genes
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Additional file 5: DESeq based differential expression data for all
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